Veracyte Reports Q3 2026 Revenue Growth, Announces $100 Million Buyback
Total revenue reached $151.8 million and testing revenue was $146.4 million, up 15% year over year. Veracyte also announced a $100 million share repurchase program.
Story updates
09:09:52 PM UTC
SquawkNews
Veracyte reported Q3 2026 revenue of $151.8M, up 15% year over year, and GAAP diluted EPS of $0.38, up $0.14. It authorized a buyback of up to $100M and narrowed 2026 revenue guidance to $590M—$593M from $590M—$596M.Material DetailsContext by AI AnalystThis is a quarterly results update showing con…
09:13:25 PM UTC
SquawkNews
BRIEF-Veracyte Q3 Revenue USD 151.8 Million Vs. IBES Estimate USD 147.4 Million